Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management
Restless legs syndrome (RLS), a common neurological sensorimotor disorder in western countries, has gained more and more attention in Asian countries. The prevalence of RLS is higher in older people and females. RLS is most commonly related to iron deficiency, pregnancy and uremia. The RLS symptoms...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnagi.2017.00171/full |
_version_ | 1811257620046020608 |
---|---|
author | Shiyi Guo Jinsha Huang Haiyang Jiang Chao Han Jie Li Xiaoyun Xu Guoxin Zhang Zhicheng Lin Zhicheng Lin Nian Xiong Tao Wang |
author_facet | Shiyi Guo Jinsha Huang Haiyang Jiang Chao Han Jie Li Xiaoyun Xu Guoxin Zhang Zhicheng Lin Zhicheng Lin Nian Xiong Tao Wang |
author_sort | Shiyi Guo |
collection | DOAJ |
description | Restless legs syndrome (RLS), a common neurological sensorimotor disorder in western countries, has gained more and more attention in Asian countries. The prevalence of RLS is higher in older people and females. RLS is most commonly related to iron deficiency, pregnancy and uremia. The RLS symptoms show a significant circadian rhythm and a close relationship to periodic limb movements (PLMs) in clinical observations, while the pathophysiological pathways are still unknown. The diagnostic criteria have been revised in 2012 to improve the validity of RLS diagnosis. Recent studies have suggested an important role of iron decrease of brain in RLS pathophysiology. Dopaminergic (DA) system dysfunction in A11 cell groups has been recognized long ago from clinical treatment and autopsy. Nowadays, it is believed that iron dysfunction can affect DA system from different pathways and opioids have a protective effect on DA system. Several susceptible single nucleotide polymorphisms such as BTBD9 and MEIS1, which are thought to be involved in embryonic neuronal development, have been reported to be associated with RLS. Several pharmacological and non-pharmacological treatment are discussed in this review. First-line treatments of RLS include DA agents and α2δ agonists. Augmentation is very common in long-term treatment of RLS which makes prevention and management of augmentation very important for RLS patients. A combination of different types of medication is effective in preventing and treating augmentation. The knowledge on RLS is still limited, the pathophysiology and better management of RLS remain to be discovered. |
first_indexed | 2024-04-12T18:00:20Z |
format | Article |
id | doaj.art-3e4b7646151444e693c0bcc75a7cf47b |
institution | Directory Open Access Journal |
issn | 1663-4365 |
language | English |
last_indexed | 2024-04-12T18:00:20Z |
publishDate | 2017-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Aging Neuroscience |
spelling | doaj.art-3e4b7646151444e693c0bcc75a7cf47b2022-12-22T03:22:11ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652017-06-01910.3389/fnagi.2017.00171224802Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and ManagementShiyi Guo0Jinsha Huang1Haiyang Jiang2Chao Han3Jie Li4Xiaoyun Xu5Guoxin Zhang6Zhicheng Lin7Zhicheng Lin8Nian Xiong9Tao Wang10Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaDepartment of Psychiatry, Harvard Medical School, BelmontMA, United StatesDivision of Alcohol and Drug Abuse, Mailman Neuroscience Research Center, McLean Hospital, BelmontMA, United StatesDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, ChinaRestless legs syndrome (RLS), a common neurological sensorimotor disorder in western countries, has gained more and more attention in Asian countries. The prevalence of RLS is higher in older people and females. RLS is most commonly related to iron deficiency, pregnancy and uremia. The RLS symptoms show a significant circadian rhythm and a close relationship to periodic limb movements (PLMs) in clinical observations, while the pathophysiological pathways are still unknown. The diagnostic criteria have been revised in 2012 to improve the validity of RLS diagnosis. Recent studies have suggested an important role of iron decrease of brain in RLS pathophysiology. Dopaminergic (DA) system dysfunction in A11 cell groups has been recognized long ago from clinical treatment and autopsy. Nowadays, it is believed that iron dysfunction can affect DA system from different pathways and opioids have a protective effect on DA system. Several susceptible single nucleotide polymorphisms such as BTBD9 and MEIS1, which are thought to be involved in embryonic neuronal development, have been reported to be associated with RLS. Several pharmacological and non-pharmacological treatment are discussed in this review. First-line treatments of RLS include DA agents and α2δ agonists. Augmentation is very common in long-term treatment of RLS which makes prevention and management of augmentation very important for RLS patients. A combination of different types of medication is effective in preventing and treating augmentation. The knowledge on RLS is still limited, the pathophysiology and better management of RLS remain to be discovered.http://journal.frontiersin.org/article/10.3389/fnagi.2017.00171/fullclinical presentationdiagnostic criteriairon deficiencydopamineA11 cell grouptreatment |
spellingShingle | Shiyi Guo Jinsha Huang Haiyang Jiang Chao Han Jie Li Xiaoyun Xu Guoxin Zhang Zhicheng Lin Zhicheng Lin Nian Xiong Tao Wang Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management Frontiers in Aging Neuroscience clinical presentation diagnostic criteria iron deficiency dopamine A11 cell group treatment |
title | Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management |
title_full | Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management |
title_fullStr | Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management |
title_full_unstemmed | Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management |
title_short | Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management |
title_sort | restless legs syndrome from pathophysiology to clinical diagnosis and management |
topic | clinical presentation diagnostic criteria iron deficiency dopamine A11 cell group treatment |
url | http://journal.frontiersin.org/article/10.3389/fnagi.2017.00171/full |
work_keys_str_mv | AT shiyiguo restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT jinshahuang restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT haiyangjiang restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT chaohan restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT jieli restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT xiaoyunxu restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT guoxinzhang restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT zhichenglin restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT zhichenglin restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT nianxiong restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement AT taowang restlesslegssyndromefrompathophysiologytoclinicaldiagnosisandmanagement |